PL374186A1 - Środek leczniczy o przedłużonym uwalnianiu substancji czynnej, zawierający 1-dimetyloamino-3-(3-metoksyfenylo)-2-metylopentan-3-ol - Google Patents

Środek leczniczy o przedłużonym uwalnianiu substancji czynnej, zawierający 1-dimetyloamino-3-(3-metoksyfenylo)-2-metylopentan-3-ol

Info

Publication number
PL374186A1
PL374186A1 PL03374186A PL37418603A PL374186A1 PL 374186 A1 PL374186 A1 PL 374186A1 PL 03374186 A PL03374186 A PL 03374186A PL 37418603 A PL37418603 A PL 37418603A PL 374186 A1 PL374186 A1 PL 374186A1
Authority
PL
Poland
Prior art keywords
pentan
dimethylamino
medicament
methoxy
phenyl
Prior art date
Application number
PL03374186A
Other languages
English (en)
Other versions
PL218397B1 (pl
Inventor
Johannes Bartholomäuse
Iris Ziegler
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of PL374186A1 publication Critical patent/PL374186A1/pl
Publication of PL218397B1 publication Critical patent/PL218397B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL374186A 2002-05-29 2003-05-26 Preparat farmaceutyczny o przedłużonym uwalnianiu, który w matrycy o przedłużonym uwalnianiu substancji czynnej, zawiera 1-dimetyloamino-3- (3-metoksyfenylo)-2- metylopentan-3-ol, oraz jego zastosowanie PL218397B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224108A DE10224108A1 (de) 2002-05-29 2002-05-29 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung

Publications (2)

Publication Number Publication Date
PL374186A1 true PL374186A1 (pl) 2005-10-03
PL218397B1 PL218397B1 (pl) 2014-11-28

Family

ID=29557413

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374186A PL218397B1 (pl) 2002-05-29 2003-05-26 Preparat farmaceutyczny o przedłużonym uwalnianiu, który w matrycy o przedłużonym uwalnianiu substancji czynnej, zawiera 1-dimetyloamino-3- (3-metoksyfenylo)-2- metylopentan-3-ol, oraz jego zastosowanie

Country Status (14)

Country Link
EP (1) EP1507519B1 (pl)
JP (1) JP5459818B2 (pl)
AR (1) AR039900A1 (pl)
AT (1) ATE326218T1 (pl)
AU (1) AU2003238397A1 (pl)
CA (1) CA2488220C (pl)
DE (2) DE10224108A1 (pl)
DK (1) DK1507519T3 (pl)
ES (1) ES2263976T3 (pl)
MY (1) MY134311A (pl)
PE (1) PE20040529A1 (pl)
PL (1) PL218397B1 (pl)
PT (1) PT1507519E (pl)
WO (1) WO2003099267A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH06172161A (ja) * 1992-12-10 1994-06-21 Shin Etsu Chem Co Ltd 徐放性錠剤
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JPH1017497A (ja) * 1996-07-02 1998-01-20 Takeda Chem Ind Ltd 徐放性製剤およびその製造方法
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
AR039900A1 (es) 2005-03-09
JP5459818B2 (ja) 2014-04-02
JP2005534640A (ja) 2005-11-17
ATE326218T1 (de) 2006-06-15
DK1507519T3 (da) 2006-08-28
WO2003099267A1 (de) 2003-12-04
DE50303372D1 (de) 2006-06-22
CA2488220A1 (en) 2003-12-04
CA2488220C (en) 2011-02-01
EP1507519B1 (de) 2006-05-17
ES2263976T3 (es) 2006-12-16
PE20040529A1 (es) 2004-08-24
MY134311A (en) 2007-12-31
AU2003238397A1 (en) 2003-12-12
DE10224108A1 (de) 2004-01-29
PT1507519E (pt) 2006-08-31
EP1507519A1 (de) 2005-02-23
PL218397B1 (pl) 2014-11-28

Similar Documents

Publication Publication Date Title
PL372084A1 (pl) Związek pochodnej 8-azaprostaglandyny i środek zawierający ten związek jako składnik aktywny
PL374390A1 (pl) Grzybobójcze kompozycje substancji czynnych
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
HU0103988D0 (en) New compounds with pharmaceutical activity
HU0103987D0 (en) New compounds with pharmaceutical activity
ZA200706254B (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
TWI345975B (en) Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
SI1608362T1 (sl) Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
EP1731524A4 (en) PHENOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE, AND ITS MEDICINAL USE
ZA200000171B (en) Analgesic with controlled active substance release.
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
EP1790336A4 (en) CAPSULE FILM COMPOSITION, CAPSULE FILM, AND CAPSULE COMPRISED THEREFROM
AU2003222823A8 (en) Physiologically compatible, phospholipid-containing, stable and hard matrix
IL167187A (en) Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
IL172666A0 (en) Compounds having anti-hcv activity and processes for the preparation thereof
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
ZA200602788B (en) Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds
AU2003269871A1 (en) Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients
SI1507519T1 (sl) Zdravilo, ki vsebuje 1-dimetilamino-3-(3-metoksi-fenil)-2-metil-pentan-3-ol, z zadrzevanim sproscanjem ucinkovine
PL374186A1 (pl) Środek leczniczy o przedłużonym uwalnianiu substancji czynnej, zawierający 1-dimetyloamino-3-(3-metoksyfenylo)-2-metylopentan-3-ol
AP2029A (en) Microcapsules for the delayed, controlled release of perindopril
HU0200306D0 (en) Method for preparation of absorbent article, the absorbent article and application of it